You can buy or sell ONTX and other stocks, options, ETFs, and crypto commission-free!
Onconova Therapeutics, Inc. Common Stock, also called Onconova Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. Read More It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
52 Week High
52 Week Low
Associated PressMar 12
Onconova Therapeutics, Inc. to Participate at the 31st Annual ROTH Conference March 17-19, 2019 in Orange County, CA
NEWTOWN, Pa., March 12, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes, today announced that the Company will participate in the 31st Annual ROTH Conference to be held March 17-19, 2019 at the Ritz Carlton Laguna Niguel in Orange County, CA. Steven M. Fruchtman, MD, President & CEO, and Mark Guerin, CFO, will attend the confe...
-$0.87 per share
Available Mar 26, Pre-Market